Summary: New research suggests that fructose produced in the brain may trigger inflammation and contribute to the development of Alzheimer’s disease.
Source: University of Colorado
Researchers at the University of Colorado Anschutz Medical Campus propose that an ancient survival mechanism—activated by fructose metabolism—could help explain the origins of Alzheimer’s disease and point to new prevention and treatment strategies.
Published in The American Journal of Clinical Nutrition, the study offers a fresh perspective on Alzheimer’s, a progressive and fatal disorder marked by abnormal protein build-up in the brain that gradually erodes memory and cognitive function.
“We make the case that Alzheimer’s disease is driven in large part by diet,” said lead author Richard Johnson, MD, a professor at the University of Colorado School of Medicine who studies kidney disease and hypertension. Co-authors include Maria Nagel, MD, research professor of neurology at the CU School of Medicine.
The team argues that Alzheimer’s may represent a maladaptive extension of an evolutionary survival pathway used by animals and early humans during periods of food scarcity.
“A central goal of living organisms is to secure enough food, water and oxygen to survive,” the study explains. “While much attention has focused on immediate responses to low oxygen or starvation, organisms also evolved anticipatory mechanisms to protect themselves before a crisis.”
When faced with possible starvation, early humans triggered a foraging response designed to increase food-seeking behavior. Effective foraging requires suppressing parts of the brain responsible for recent memory, time awareness and self-restraint so that attention and risk-taking can focus on finding food.
Fructose—a type of sugar—helps dampen those brain regions and thereby promotes the behaviors needed for productive foraging. The researchers found that this response can be activated either by consuming fructose or by the body producing fructose internally.
Metabolizing fructose and its byproduct, intracellular uric acid, appears to play a central role in this survival program. The study notes that fructose reduces blood flow and metabolism in the cerebral cortex areas involved in self-control, as well as in the hippocampus and thalamus, while increasing blood flow in visual areas linked to food reward—changes that together facilitate a foraging state.
“Initially, the fructose-driven reduction in metabolism in these regions was likely reversible and beneficial,” Johnson said. “But when this pathway is repeatedly engaged over long periods—especially in an environment of plentiful high-fat, sugary and salty foods—it leads to persistent reductions in cerebral metabolism, progressive brain atrophy and neuron loss consistent with Alzheimer’s disease.”
Johnson and colleagues describe this conserved reaction as a “survival switch.” In modern settings of constant food availability, that switch may remain chronically active, encouraging overconsumption of energy-dense foods and stimulating excess fructose production in the body and brain.
According to the study, intracerebral fructose metabolism triggers inflammation and other cellular changes that can damage neurons. Animal studies cited by the authors show that rodents fed high-fructose diets develop memory deficits, impaired navigation, neuronal inflammation and, after sustained exposure, the hallmark Alzheimer’s proteins tau and amyloid beta.
“Sustained fructose exposure in laboratory animals produces many features seen in Alzheimer’s disease, and elevated fructose levels have been observed in human Alzheimer’s brains,” Johnson noted. The authors also speculate that wandering behavior sometimes seen in Alzheimer’s patients may reflect remnants of the ancient foraging response.
The researchers stress that additional work is needed to clarify the roles of fructose and uric acid metabolism in Alzheimer’s disease. They recommend clinical trials that test whether reducing dietary fructose or pharmacologically blocking fructose metabolism can help prevent, slow, or treat Alzheimer’s.
About this Alzheimer’s disease research news
Author: Press Office
Source: University of Colorado
Contact: Press Office – University of Colorado
Image: The image is in the public domain
Original Research: Open access.
“Could Alzheimer’s disease be a maladaptation of an evolutionary survival pathway mediated by intracerebral fructose and uric acid metabolism?” by Richard J. Johnson et al., American Journal of Clinical Nutrition
Abstract
Could Alzheimer’s disease be a maladaptation of an evolutionary survival pathway mediated by intracerebral fructose and uric acid metabolism?
Securing sufficient food, water and oxygen is vital for survival. This review outlines a recently described physiological response that promotes survival during scarcity and can be triggered by either the ingestion or endogenous production of fructose.
Unlike glucose, which primarily supplies immediate energy, fructose metabolism initiates a coordinated set of changes: it stimulates appetite and water intake, reduces resting metabolism, promotes fat and glycogen storage, and induces insulin resistance. These effects collectively lower overall metabolic demand and help preserve glucose for critical brain functions.
Because the brain consumes roughly 20% of resting energy, alterations in cerebral metabolism have significant consequences. The authors revisit and expand a prior hypothesis proposing that chronic activation of this fructose-driven survival pathway may underlie many early features of Alzheimer’s disease, including reduced cerebral glucose metabolism, mitochondrial dysfunction, and neuroinflammation.
The pathway may be activated through multiple routes, including diets high in sugar, refined carbohydrates, and salt. In short, a mechanism that once offered an evolutionary advantage during brief periods of scarcity can become harmful when persistently engaged in modern environments of abundance.
While further studies are required to define the roles of fructose and uric acid in Alzheimer’s disease, the authors recommend testing dietary interventions and pharmacologic approaches that reduce fructose exposure or block fructose metabolism to evaluate their potential in prevention, management, or treatment.